These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation. Abela GS J Clin Lipidol; 2010; 4(3):156-64. PubMed ID: 21122648 [TBL] [Abstract][Full Text] [Related]
3. Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. Abela GS; Vedre A; Janoudi A; Huang R; Durga S; Tamhane U Am J Cardiol; 2011 Jun; 107(12):1710-7. PubMed ID: 21507364 [TBL] [Abstract][Full Text] [Related]
4. [Anti-atherosclerotic and anti-inflammatory effects of statin on cardiovascular disease and their mechanisms]. Ishibashi T Nihon Rinsho; 2011 Jan; 69(1):79-84. PubMed ID: 21226265 [TBL] [Abstract][Full Text] [Related]
6. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview. Nidorf SM; Thompson PL Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286 [TBL] [Abstract][Full Text] [Related]
7. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention. Chapman MJ Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923 [TBL] [Abstract][Full Text] [Related]
8. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis. Girotra S; Murarka S; Migrino RQ Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562 [TBL] [Abstract][Full Text] [Related]
9. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering. Pedersen TR Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729 [TBL] [Abstract][Full Text] [Related]
10. Effects of Arnica comp.-Heel® on reducing cardiovascular events in patients with stable coronary disease. Fioranelli M; Bianchi M; Roccia MG; Di Nardo V Minerva Cardioangiol; 2016 Feb; 64(1):34-40. PubMed ID: 26989948 [TBL] [Abstract][Full Text] [Related]
11. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia. Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472 [TBL] [Abstract][Full Text] [Related]
16. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?]. Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606 [TBL] [Abstract][Full Text] [Related]
17. Statins and atherosclerosis: the role of epigenetics. Storino Farina M; Rojano Rada J; Molina Garrido A; Martínez X; Pulgar A; Paniagua R; Garrido J Medwave; 2015 Nov; 15(10):e6324. PubMed ID: 26639162 [TBL] [Abstract][Full Text] [Related]
18. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins. Clearfield MB J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 4):S2-6. PubMed ID: 20453192 [TBL] [Abstract][Full Text] [Related]
20. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? Mora S; Ridker PM Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]